HCA Healthcare/$HCA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About HCA Healthcare
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Ticker
$HCA
Sector
Primary listing
NYSE
Employees
271,000
Headquarters
Website
HCA Healthcare Metrics
BasicAdvanced
$94B
16.99
$23.73
1.40
$2.76
0.71%
Price and volume
Market cap
$94B
Beta
1.4
52-week high
$420.98
52-week low
$289.98
Average daily volume
1.1M
Dividend rate
$2.76
Financial strength
Current ratio
0.976
Quick ratio
0.715
Long term debt to equity
-3,332.795
Total debt to equity
-3,745.073
Dividend payout ratio (TTM)
11.47%
Interest coverage (TTM)
5.13%
Profitability
EBITDA (TTM)
14,499
Gross margin (TTM)
40.89%
Net profit margin (TTM)
8.21%
Operating margin (TTM)
15.24%
Effective tax rate (TTM)
21.60%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
11.84%
Return on equity (TTM)
13,631.68%
Valuation
Price to earnings (TTM)
16.991
Price to revenue (TTM)
1.379
Price to book
-21.67
Price to tangible book (TTM)
-6.65
Price to free cash flow (TTM)
13.734
Free cash flow yield (TTM)
7.28%
Free cash flow per share (TTM)
29.355
Dividend yield (TTM)
0.68%
Forward dividend yield
0.71%
Growth
Revenue change (TTM)
6.37%
Earnings per share change (TTM)
11.48%
3-year revenue growth (CAGR)
6.55%
10-year revenue growth (CAGR)
6.58%
3-year earnings per share growth (CAGR)
4.21%
10-year earnings per share growth (CAGR)
17.13%
3-year dividend per share growth (CAGR)
9.89%
What the Analysts think about HCA Healthcare
Analyst ratings (Buy, Hold, Sell) for HCA Healthcare stock.
Bulls say / Bears say
HCA posted adjusted EPS of $6.84 in Q2, above analyst estimates, and same-facility revenue per equivalent admission rose 4.0% year-over-year, demonstrating strong pricing and operational efficiency. (Reuters)
The company raised 2025 full-year guidance, lifting revenue to $74.0–$76.0 billion, adjusted EBITDA to $14.7–$15.3 billion, and diluted EPS to $25.50–$27.00, reflecting management’s confidence in ongoing growth and margin gains. (WSJ)
In Q2 2025, HCA repurchased 7.03 million shares for $2.505 billion under its $10 billion buyback authorization, leaving $5.753 billion remaining, further highlighting strong free cash flow and a focus on returning capital to shareholders. (SEC)
Q2 2025 same-facility inpatient surgeries fell 0.3% and outpatient surgeries fell 0.6%, indicating possible softness in higher-margin surgical services. (Reuters)
As of June 30, 2025, total debt was $44.483 billion with only $939 million in cash, highlighting a highly leveraged balance sheet and raising concerns over interest rate and refinancing risk. (SEC)
HCA’s 2025 capital expenditure plan of $5.0–$5.2 billion, excluding acquisitions, could put pressure on free cash flow and constrain discretionary spending as the company faces significant network investment needs. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.
HCA Healthcare Financial Performance
Revenues and expenses
HCA Healthcare Earnings Performance
Company profitability
HCA Healthcare News
AllArticlesVideos
Home Connectivity Alliance Announces HCA Energy Management Specification 2.0 and HCA Insurance Specification at IFA 2025
Business Wire2 weeks ago
HCA Healthcare, Inc. to Present at September Healthcare Conference
Business Wire3 weeks ago
Can HCA Healthcare Revive the Market's Weakest Sector?
MarketBeat2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept30
HCA Healthcare
DividendPayment
$0.72Per share
FAQs
What’s the current market cap for HCA Healthcare stock?
HCA Healthcare (HCA) has a market cap of $94B as of September 16, 2025.
What is the P/E ratio for HCA Healthcare stock?
The price to earnings (P/E) ratio for HCA Healthcare (HCA) stock is 16.99 as of September 16, 2025.
Does HCA Healthcare stock pay dividends?
Yes, the HCA Healthcare (HCA) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $2.76 and the yield is 0.71%. HCA Healthcare has a payout ratio of 11.47% on a trailing twelve-month basis.
When is the next HCA Healthcare dividend payment date?
The next HCA Healthcare (HCA) dividend payment is scheduled for September 30, 2025.
What is the beta indicator for HCA Healthcare?
HCA Healthcare (HCA) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.